Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

129 trials

NCT05131022
Recruiting
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Phase 1 · Switzerland, Spain, France, United Kingdom, Italy, Netherlands, Poland, United States · 62 sites
Registry update: 2 Jul 2026
NCT05098613
Recruiting
Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients
Phase 1 · United States · 1 site
Registry update: 9 Jul 2026
NCT05006716
Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Phase 1/2 · Australia, Brazil, Canada, China, Germany, Spain, France, United Kingdom, Georgia, Italy, Japan, South Korea, Moldova, Sweden, Türkiye, United States · 114 sites
Registry update: 5 Oct 2026
NCT04883437
Recruiting
Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas
Phase 2 · United States · 1 site
Registry update: 9 Feb 2026
NCT04491370
Recruiting
Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma
Phase 1/2 · United States · 1 site
Registry update: 15 Apr 2026
NCT04775745
Recruiting
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
Phase 1 · United States · 4 sites
Registry update: 13 Feb 2026
NCT04855695
Recruiting
Avo In R/R And Previously Untreated MCL
Phase 1/2 · United States · 3 sites
Registry update: 21 Jan 2026
NCT04792489
Recruiting
DALY II USA/ MB-CART2019.1 for DLBCL
Phase 2 · Canada, Croatia, Hungary, United States · 34 sites
Registry update: 13 Jul 2026
Conflicting statuses (not updated in the registry for 3 months)
NCT04830137
Recruiting
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Phase 1 · United States · 16 sites
Registry update: 20 Mar 2026
NCT04368702
Recruiting
CONFIRM: Magnetic Resonance Guided Radiation Therapy
Not applicable · United States · 2 sites
Registry update: 9 Feb 2026
NCT04195633
Recruiting
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
Phase 2 · United States · 1 site
Registry update: 29 May 2026
NCT04223765
Recruiting
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Phase 1 · United States · 1 site
Registry update: 20 Jan 2026
NCT04329728
Recruiting
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Phase 1/2 · United States · 11 sites
Registry update: 15 Apr 2026
NCT04807881
Recruiting
Phase Ib Clinical Study of Keynatinib
Phase 1 · China · 4 sites
Registry update: 29 Oct 2026
NCT04545762
Recruiting
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
Phase 1 · United States · 1 site
Registry update: 26 Oct 2026
NCT04186520
Recruiting
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
Phase 1/2 · United States · 1 site
Registry update: 23 Feb 2026
NCT06339255
Recruiting
Italian Observational Study on CAR-T Therapy for Lymphoma
Not applicable · Italy · 1 site
Registry update: 1 Apr 2024
NCT03930953
Recruiting
An early study to investigate a new medicine for Subjects with Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)
Phase 1/2 · Denmark, Spain, France, Italy · 21 sites
Registry update: 11 Nov 2026
NCT03523975
Recruiting
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
Phase 1/2 · United States · 4 sites
Registry update: 14 Oct 2026
NCT03869619
Recruiting
REal World Data in LYmphoma and Survival in Adults
Not applicable · France · 37 sites
Registry update: 28 Jun 2021

Ordered by registry start date. Freshness and sponsorship never change the order.